普通外科指南

订阅

MedSci主页 / 所有栏目 / 普通外科指南

2021 共识声明：复杂腹壁疝围术期优化

2021-09-20 国外普通外科相关专家组（统称） BJS Open

复杂腹壁疝

腹壁重建（AWR）是一个快速发展的亚专业化领域，短期随访中，通过中线剖腹手术后腹壁切口疝（AWH）的发生率为20%-41%。

中文标题：

2021 共识声明：复杂腹壁疝围术期优化

英文标题：

Perioperative optimization in complex abdominal wall hernias: Delphi consensus statement

发布机构：

国外普通外科相关专家组（统称）

发布日期：

2021-09-20

简要介绍：

腹壁重建（AWR）是一个快速发展的亚专业化领域，短期随访中，通过中线剖腹手术后腹壁切口疝（AWH）的发生率为20%-41%。本文主要针对复杂腹壁疝围术期优化提供共识建议，目的是为接受AWR患者的术前评估和围术期优化提供明确的护理基准。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 共识声明：复杂腹壁疝围术期优化.pdf)] GetToolGuiderByIdResponse(projectId=1, id=9c5611c00219889b, title=2021 共识声明：复杂腹壁疝围术期优化, enTitle=Perioperative optimization in complex abdominal wall hernias: Delphi consensus statement, guiderFrom=BJS Open, authorId=0, author=, summary=腹壁重建（AWR）是一个快速发展的亚专业化领域，短期随访中，通过中线剖腹手术后腹壁切口疝（AWH）的发生率为20%-41%。, cover=https://img.medsci.cn/2021930/1633006081228_5579292.jpg, journalId=0, articlesId=null, associationId=1346, associationName=国外普通外科相关专家组（统称）, associationIntro=, copyright=0, guiderPublishedTime=Mon Sep 20 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">腹壁重建（AWR）是一个快速发展的亚专业化领域，短期随访中，通过中线剖腹手术后腹壁切口疝（AWH）的发生率为20%-41%。本文主要针对复杂腹壁疝围术期优化提供共识建议，目的是为接受AWR患者的术前评估和围术期优化提供明确的护理基准。</span></p>, tagList=[TagDto(tagId=115473, tagName=复杂腹壁疝)], categoryList=[CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=91722, guiderKeyword=腹壁疝, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5636, appHits=60, showAppHits=0, pcHits=1546, showPcHits=5576, likes=1, shares=4, comments=6, approvalStatus=1, publishedTime=Thu Sep 30 20:59:44 CST 2021, publishedTimeString=2021-09-20, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Thu Sep 30 20:54:51 CST 2021, updatedBy=6415643, updatedName=凯晨, updatedTime=Sat Jan 06 10:35:15 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 共识声明：复杂腹壁疝围术期优化.pdf)])
2021 共识声明：复杂腹壁疝围术期优化.pdf
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1200741, encodeId=d1a21200e41a3, content=好好学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dedb2509386, createdName=124b7227m12暂无昵称, createdTime=Wed Mar 09 00:09:09 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200740, encodeId=52f81200e4076, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dedb2509386, createdName=124b7227m12暂无昵称, createdTime=Wed Mar 09 00:08:52 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084399, encodeId=6366108439907, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210612/26f2350e29834929821d84c500105a4f/b3a9564565d4455894dedc4f51cd2ed0.jpg, createdBy=5d3d5518859, createdName=大旭, createdTime=Sun Dec 26 14:16:40 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082057, encodeId=fd65108205e0a, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5455085993, createdName=145c2665m10暂无昵称, createdTime=Mon Dec 20 12:18:34 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056752, encodeId=02f71056e5253, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:09:19 CST 2021, time=2021-10-01, status=1, ipAttribution=)]
    2022-03-09 124b7227m12暂无昵称

    好好学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1200741, encodeId=d1a21200e41a3, content=好好学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dedb2509386, createdName=124b7227m12暂无昵称, createdTime=Wed Mar 09 00:09:09 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200740, encodeId=52f81200e4076, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dedb2509386, createdName=124b7227m12暂无昵称, createdTime=Wed Mar 09 00:08:52 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084399, encodeId=6366108439907, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210612/26f2350e29834929821d84c500105a4f/b3a9564565d4455894dedc4f51cd2ed0.jpg, createdBy=5d3d5518859, createdName=大旭, createdTime=Sun Dec 26 14:16:40 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082057, encodeId=fd65108205e0a, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5455085993, createdName=145c2665m10暂无昵称, createdTime=Mon Dec 20 12:18:34 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056752, encodeId=02f71056e5253, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:09:19 CST 2021, time=2021-10-01, status=1, ipAttribution=)]
    2022-03-09 124b7227m12暂无昵称

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1200741, encodeId=d1a21200e41a3, content=好好学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dedb2509386, createdName=124b7227m12暂无昵称, createdTime=Wed Mar 09 00:09:09 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200740, encodeId=52f81200e4076, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dedb2509386, createdName=124b7227m12暂无昵称, createdTime=Wed Mar 09 00:08:52 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084399, encodeId=6366108439907, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210612/26f2350e29834929821d84c500105a4f/b3a9564565d4455894dedc4f51cd2ed0.jpg, createdBy=5d3d5518859, createdName=大旭, createdTime=Sun Dec 26 14:16:40 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082057, encodeId=fd65108205e0a, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5455085993, createdName=145c2665m10暂无昵称, createdTime=Mon Dec 20 12:18:34 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056752, encodeId=02f71056e5253, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:09:19 CST 2021, time=2021-10-01, status=1, ipAttribution=)]
    2021-12-26 大旭

    谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1200741, encodeId=d1a21200e41a3, content=好好学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dedb2509386, createdName=124b7227m12暂无昵称, createdTime=Wed Mar 09 00:09:09 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200740, encodeId=52f81200e4076, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dedb2509386, createdName=124b7227m12暂无昵称, createdTime=Wed Mar 09 00:08:52 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084399, encodeId=6366108439907, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210612/26f2350e29834929821d84c500105a4f/b3a9564565d4455894dedc4f51cd2ed0.jpg, createdBy=5d3d5518859, createdName=大旭, createdTime=Sun Dec 26 14:16:40 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082057, encodeId=fd65108205e0a, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5455085993, createdName=145c2665m10暂无昵称, createdTime=Mon Dec 20 12:18:34 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056752, encodeId=02f71056e5253, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:09:19 CST 2021, time=2021-10-01, status=1, ipAttribution=)]
    2021-12-20 145c2665m10暂无昵称

    谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1200741, encodeId=d1a21200e41a3, content=好好学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dedb2509386, createdName=124b7227m12暂无昵称, createdTime=Wed Mar 09 00:09:09 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200740, encodeId=52f81200e4076, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dedb2509386, createdName=124b7227m12暂无昵称, createdTime=Wed Mar 09 00:08:52 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084399, encodeId=6366108439907, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210612/26f2350e29834929821d84c500105a4f/b3a9564565d4455894dedc4f51cd2ed0.jpg, createdBy=5d3d5518859, createdName=大旭, createdTime=Sun Dec 26 14:16:40 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082057, encodeId=fd65108205e0a, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5455085993, createdName=145c2665m10暂无昵称, createdTime=Mon Dec 20 12:18:34 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056752, encodeId=02f71056e5253, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:09:19 CST 2021, time=2021-10-01, status=1, ipAttribution=)]
    2021-10-01 13f0c37dm61暂无昵称

    谢谢分享

    0

拓展阅读

2019 IEHS指南：腹壁疝和腹壁切口疝的内镜治疗（更新版）-A

国际内镜疝学会(IEHS,International Endohernia Society) · 2019-06-27

国际内镜疝学会腹壁疝和切口疝腹腔镜治疗指南更新解读（二）

暂未更新 · 2019-10-30

2020 EHS/AHS指南：罕见部位或特殊情况下原发性腹壁疝的治疗

欧洲疝学会(EHS,the European Hernia Society) · 2020-03-20

2023 意大利指南：腹壁疝的腹腔镜治疗

国外普通外科相关专家组（统称） · 2023-05-22